WallStreetZenWallStreetZen

NASDAQ: LYRA
Lyra Therapeutics Inc Stock Ownership - Who owns Lyra Therapeutics?

Insider buying vs selling

Have Lyra Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Harlan WaksalExecutive Chair2023-11-1025,000$2.96
$74.10kBuy
Edward T. AndersonDirector2023-05-31197,946$2.43
$481.01kBuy
Edward T. AndersonDirector2023-05-31403,858$2.43
$981.37kBuy
Nbvm GP LLC10% Owner2023-05-311,203,612$2.43
$2.92MBuy
Edward T. AndersonDirector2023-05-311,203,612$2.43
$2.92MBuy
Nbvm GP LLC10% Owner2023-05-31403,858$2.43
$981.37kBuy
Perceptive Advisors LLCDirector2023-05-313,610,832$2.49
$9.00MBuy
Nbvm GP LLC10% Owner2023-05-31197,946$2.43
$481.01kBuy

1 of 1

LYRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when LYRA insiders and whales buy or sell their stock.

LYRA Shareholders

What type of owners hold Lyra Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Perceptive Advisors LLC21.35%12,757,562$78.20MInstitution
Nantahala Capital Management LLC6.78%4,050,218$24.83MInstitution
Vestal Point Capital LP5.02%3,000,000$18.39MInstitution
Point72 Asset Management LP5.02%3,000,000$18.39MInstitution
Citadel Advisors LLC4.79%2,861,255$17.54MInstitution
Samsara Biocapital LLC4.65%2,780,261$17.04MInstitution
Edward T. Anderson4.42%2,640,228$16.18MInsider
Perceptive Advisors LLC4.31%2,576,892$15.80MInsider
Vr Adviser LLC4.31%2,575,593$15.79MInstitution
Nbvm GP LLC4.22%2,521,745$15.46MInsider

1 of 3

LYRA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
LYRA70.88%14.48%Net Buying
ADAP7.28%92.72%Net SellingNet Selling
KOD67.33%32.67%Net Selling
MNMD10.01%89.99%Net SellingNet Selling
THRD73.29%26.71%Net Buying

Lyra Therapeutics Stock Ownership FAQ

Who owns Lyra Therapeutics?

Lyra Therapeutics (NASDAQ: LYRA) is owned by 70.88% institutional shareholders, 14.48% Lyra Therapeutics insiders, and 14.64% retail investors. Edward T. Anderson is the largest individual Lyra Therapeutics shareholder, owning 2.64M shares representing 4.42% of the company. Edward T. Anderson's Lyra Therapeutics shares are currently valued at $17.24M.

If you're new to stock investing, here's how to buy Lyra Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.